Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers - Wikidata - wikimedia - TriplyDB

Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers

Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers

http://www.wikidata.org/entity/Q33606794

about

Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier Nanoengineering approaches to the design of artificial antigen-presenting cells Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm Nanocarriers for vascular delivery of antioxidants Macrophages recognize size and shape of their targets Icam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammation Dynamics of receptor-mediated nanoparticle internalization into endothelial cells Microfluidic devices for modeling cell–cell and particle–cell interactions in the microvasculature Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase Polymer particles that switch shape in response to a stimulus.Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism.On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better.Margination of micro- and nano-particles in blood flow and its effect on drug delivery.Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.Alternatives to allogeneic platelet transfusion.Design of Functional Materials based on Liquid Crystalline Droplets An integrated approach for the rational design of nanovectors for biomedical imaging and therapy.Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines.Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles An inside job: how endosomal Na(+)/H(+) exchangers link to autism and neurological disease Internalization of red blood cell-mimicking hydrogel capsules with pH-triggered shape responses Endocytosis of nanomedicines.Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.Needle-shaped polymeric particles induce transient disruption of cell membranes.PRINT: a novel platform toward shape and size specific nanoparticle theranostics.Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments.USNCTAM perspectives on mechanics in medicine.In situ re-endothelialization via multifunctional nanoscaffolds.A strategy in the design of micellar shape for cancer therapy.Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers Targeted modulation of reactive oxygen species in the vascular endothelium Shape switching of hollow layer-by-layer hydrogel microcontainers.

P2860

Q26778701-95E77407-43DD-44FC-8F60-109C6F9E8179 Q26798467-98CA772B-24E6-4A9C-9F2E-51BEC139FBA4 Q26801300-C611F6C0-4619-49F7-83A7-C845783D47F4 Q27023634-086E069D-05BD-494E-BA60-F0A2B4344F51 Q27026630-C0107222-19BB-4210-A0BA-3B2E72A23682 Q27027067-145E3D07-E27B-452F-AA96-3E28731B5BCF Q28473589-D2E3E09C-FEB6-4995-B511-6604578D0F25 Q28540684-DD212BB9-0AF8-4AEB-8331-C002B403570B Q28546649-AC874456-B668-4EB4-A2A2-CA9869E863B1 Q29541085-85CC043B-D6B0-4569-B1D6-C3DA5D106F7E Q30466992-0B4A5CC0-9D92-4565-BAAB-CC525CD68BE9 Q30489269-D011C49D-8AA9-47A0-BEA8-47B02FC2F900 Q30495236-8B9DE12C-F39E-4C36-9DA9-4D6B8F94C81A Q30501687-1EFE7117-2A2D-4166-AA2B-E37AEED13399 Q30540909-C84EE68E-ECB2-4902-B49F-9419F48FC76D Q30577405-41379F5A-53B2-447C-8E3F-D41A07D9C194 Q30818713-F9C60A67-C1F8-4AE1-8E9B-C353F2367C04 Q33435484-EDF1C28E-389E-4A86-AF03-D27C49FE9393 Q33678413-34D01D85-2EDD-43AF-93B7-353BB02C39F6 Q33679533-364A107C-3495-4DC8-A742-473A0C0A16E3 Q33752929-FA5DF012-9114-4FBB-BF71-AA43E84D75E1 Q33755231-905C6014-099F-4247-B109-1407110D1C93 Q33791880-0130FD0E-9E6E-474A-ADC0-09547D9C6359 Q33824885-8F874F50-F976-4C67-B33B-6F1D93C85005 Q33987301-04B59A5B-77E0-4DFE-9FCC-BD63CC2D1956 Q34028831-80EB0CF6-56DE-4354-9010-19E7B807ACF2 Q34028841-64CA026E-5398-4ADC-B191-8964EA4DE556 Q34072375-33F2454B-7AD5-4ACF-B257-58D74A9FE41C Q34119423-44989900-2D8B-4BAC-96B7-2D691EA6A326 Q34147654-A09D6F8E-E7A0-41EA-B5BE-4E90A345B794 Q34149121-CF703DE5-1112-49DB-BB5B-C2A54B35A224 Q34151664-2A5F6BCD-C63D-4B95-B4CC-2E7E32309095 Q34398830-6AA549C8-5C71-4177-9408-9DA9C58D86A3 Q34419883-DAECCCA2-795D-40F5-AA6B-CF9C75A96D5F Q34489400-B934B8FE-C3EF-4C8E-818A-957947736F83 Q34593961-92FB41E1-E0F9-4726-9568-2483AF86DE80 Q34631547-7CB749F3-7711-4D97-BE98-18991B49F2F4 Q34690444-3523F14A-692C-461B-AEA0-BFC9C34038C9 Q35098774-9948E137-6D6F-44D4-A6CB-CD8A21D3AD98 Q35100232-3F499D62-5A79-4BEB-B74C-24CC8591F31F

P2860

Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers

http://www.wikidata.org/entity/Q33606794

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@ast

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@en

type

label

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@ast

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@en

prefLabel

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@ast

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@en

P1433

Q33606794-D426F50B-AD94-4AB7-80EB-1F463C6C9B49

P1476

Q33606794-220DC619-2EDC-4273-9921-170D68045C7D

P2093

Q33606794-130F6376-7680-4EB8-880D-11149E0FA98C

Q33606794-4A09FE7E-F915-4576-91D3-09E8FE77E4C6

Q33606794-804AC1F7-6BE8-4E23-AEA5-776D3F0E7A2D

Q33606794-9F72EB6B-AD67-4A75-9B8E-4A07BFBDCF3E

Q33606794-A40465CB-A096-41ED-92FC-3118C65D8BAC

Q33606794-CE71A874-8CAE-49FE-A4DE-E7D37253E833

Q33606794-D439F049-DBE8-4605-AD32-C5549C8B63E8

P2860

Q33606794-09ECCF72-8FF9-4A99-B73D-D0FDD9D944DF

Q33606794-0B8A3CD2-5BA2-4187-8BA1-74253E1E90CE

Q33606794-1452C420-6B3F-460B-93FD-B24314C9447C

Q33606794-1578428F-0B1A-4360-9DC4-8FDABEDECD16

Q33606794-2BC4FEDC-B780-40D4-99E5-424D9151775A

Q33606794-3D30784C-85E3-4EE2-AC95-869FD4CB2C56

Q33606794-4012FF13-168E-40E8-B3CE-D61B55D31949

Q33606794-591DFC7F-B63F-4DCB-92AA-253F26CB2981

Q33606794-648FD1C9-5E63-4387-82D7-D3F5CC8A14A0

Q33606794-67D71D94-4726-4AF0-933C-6FAAE3486C09

P304

Q33606794-95FF083A-4C2F-4784-A6E9-62316E6528EF

P31

Q33606794-CCC6510A-D558-464A-AE32-4DEE5F23FBD8

P356

Q33606794-8B1E50EE-EB35-4082-A5EC-833D23E17339

P433

Q33606794-C1DA293B-930C-4F5B-8F09-EBBD5DF00A01

P478

Q33606794-D06BC0E3-89CB-4049-8ECD-81320BABA1DE

P50

Q33606794-55E6E682-A429-4657-8B07-7BA883031BA9

P577

Q33606794-E6305E0D-2159-4334-B8FE-FFCB29B29BB0

P5875

Q33606794-CC8F01EE-807B-46EB-BEB9-216D461744F8

P698

Q33606794-3D3910F8-DCFD-4C10-B190-68637851597B

P921

Q33606794-5FA2458B-7085-4D72-999A-3F0D7FBA797D

P932

Q33606794-A85363FB-86C6-4D76-9ED3-A8392190057E

P356

P1433

Molecular Therapy

P1476

Control of endothelial targeti ...... pe of ICAM-1-targeted carriers

@en

P2093

Christine Gajewski

http://www.w3.org/2001/XMLSchema#string

Edward H Schuchman

http://www.w3.org/2001/XMLSchema#string

John Leferovich

http://www.w3.org/2001/XMLSchema#string

Julie A Champion

http://www.w3.org/2001/XMLSchema#string

Samir Mitragotri

http://www.w3.org/2001/XMLSchema#string

Silvia Muro

http://www.w3.org/2001/XMLSchema#string

Vladimir R Muzykantov

http://www.w3.org/2001/XMLSchema#string

P2860

Role of target geometry in phagocytosis.

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung

17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange.

Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy.

Tumor vasculature directed drug targeting: applying new technologies and knowledge to the development of clinically relevant therapies.

Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Caveolin regulation of endothelial function.

Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.

Targeted delivery of therapeutic oligonucleotides to pulmonary circulation.

P304

1450-1458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2008.127

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Carmen Garnacho

P577

2008-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5295149

http://www.w3.org/2001/XMLSchema#string

P698

18560419

http://www.w3.org/2001/XMLSchema#string

P921

P932

2810502

http://www.w3.org/2001/XMLSchema#string